Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immunocore Holdings Plc ADR (NQ: IMCR )

57.20 +0.53 (+0.94%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Immunocore Holdings Plc ADR

< Previous 1 2 3 Next >
Expert Ratings for Immunocore Hldgs
 
Via Benzinga
Recap: Immunocore Hldgs Q1 Earnings
 
Via Benzinga
Short Volatility Alert: Immunocore Hldgs
On Friday, shares of Immunocore Hldgs (NASDAQ: IMCR) experienced volatile short activity. After the activity, the stock price went up +3.38% to $54.81. The overall sentiment for IMCR has been Bearish. 
Via Benzinga
Analyst Ratings for Immunocore Hldgs
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2023
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Earnings Scheduled For March 1, 2023
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million. 
Via Benzinga
Preview: Immunocore Holdings's Earnings
 
Via Benzinga
Immunocore Reveals First Data From HIV Infection Candidate Study
 
Via Benzinga
Biotech's Drug Pipeline Expands From Melanoma To Other Cancers
Immunocore is the IBD Stock of the Day as the biotech company expands its pipeline. Earnings For IMCR stock are due in March. 
Via Investor's Business Daily
3 Pharma Stocks That Will Mint Millionaires
These pharma stocks all have excellent risk-reward ratios and the companies have developed treatments that could easily become blockbusters. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2022
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2022
 
Via Benzinga
Analyst Ratings for Immunocore Hldgs
 
Via Benzinga
Where Immunocore Hldgs Stands With Analysts
 
Via Benzinga
7 Analysts Have This to Say About Immunocore Hldgs
 
Via Benzinga
Where Immunocore Hldgs Stands With Analysts
Immunocore Hldgs (NASDAQ:IMCR) has observed the following analyst ratings within the last quarter: 
Via Benzinga
What 6 Analyst Ratings Have To Say About Immunocore Hldgs
Analysts have provided the following ratings for Immunocore Hldgs (NASDAQ:IMCR) within the last quarter: 
Via Benzinga
5 Analysts Have This to Say About Immunocore Hldgs
Within the last quarter, Immunocore Hldgs (NASDAQ:IMCR) has observed the following analyst ratings: 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  During Monday's session, 50 stocks hit new 52-week highs. 
Via Benzinga
Procter & Gamble To Jump Over 16%? Here Are 5 Other Price Target Changes For Monday
 
Via Benzinga
After Bill Gates Dumps Billions In Berkshire To Buy Microsoft, His Quiet Biotech Portfolio Has Made A New Trade
Bill Gates has two portfolios he makes trades from: the Bill & Melinda Gates Foundation and the Bill & Melinda Gates Foundation Trust. 
Via Benzinga
Immunocore Shares Fall After Early Solid Cancer Trial Data Of TCR Therapy
 
Via Benzinga
Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday
Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in... 
Via Benzinga
Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary
 
Via Benzinga
Dow Climbs More Than 400 Points, S&P 500 Rises 1.5%
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 400 points on Friday. 
Via Benzinga
Stocks Extend Gains, Weekly Wins In Sight
Stocks are extending this morning's gains, with the Dow Jones Industrial Average last seen up 317 points. 
Via Talk Markets
Analyzing Immunocore Hldgs's Short Interest
Immunocore Hldgs's (NASDAQ:IMCR) short percent of float has fallen 15.71% since its last report. The company recently reported that it has 902 thousand shares sold short, which is... 
Via Benzinga
Why Zscaler Is Trading Higher By Around 19%, Here Are 44 Stocks Moving In Friday's Mid-Day Session
Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares jumped 70% to $2.1750 after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in cash. 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.